Departments of Anesthesiology and Critical Care Medicine, Quality and Safety Research Group, John Hopkins University School of Medicine, Baltimore, MD, USA,
Curr Infect Dis Rep. 2011 Aug;13(4):343-9. doi: 10.1007/s11908-011-0186-8.
Central line-associated blood stream infections (CLABSI) are among the most common, lethal, and costly health care-associated infections. Recent large collaborative quality improvement efforts have achieved unprecedented and sustained reductions in CLABSI rates and demonstrate that these infections are largely preventable, even for exceedingly ill patients. The broad acceptance that zero CLABSI rates are an achievable goal has motivated and stimulated diverse groups of stakeholders, including public and private groups to develop policy tools and to mobilize their local constituents toward achieving this goal. Nevertheless, attributing reductions in CLABSI rates achieved by multifaceted quality improvement efforts solely to the use of checklists to ensure adherence with appropriate infection control practices is an easily made but crucial mistake. National CLABSI prevention is a shared responsibility and creating novel partnerships between government agencies, health care industry, and consumers is critical to making and sustaining progress in achieving the goals toward eliminating CLABSI.
中心静脉导管相关性血流感染（CLABSI）是最常见、最致命和最昂贵的医疗保健相关感染之一。最近，大规模的合作质量改进努力取得了前所未有的、持续的 CLABSI 率降低，并证明这些感染在很大程度上是可以预防的，即使是对病情极其严重的患者也是如此。广泛认为零 CLABSI 率是一个可以实现的目标，这激发和激励了包括公共和私营团体在内的不同利益相关者群体制定政策工具，并动员其当地成员努力实现这一目标。然而，将多方面质量改进努力所取得的 CLABSI 率降低归因于检查表的使用，以确保遵守适当的感染控制措施，这是一个很容易犯但至关重要的错误。国家 CLABSI 预防是一项共同的责任，在政府机构、医疗保健行业和消费者之间建立新的伙伴关系对于在实现消除 CLABSI 的目标方面取得和维持进展至关重要。
